Skip to main content
. 2017 May 23;14(1):35–42. doi: 10.3892/etm.2017.4501

Table I.

Inhibition rate of survivin siRNA on cancer cell lines.

Inhibition rate (mean ± standard deviation, %)

Cell lines Groups 24 h 48 h 72 h 96 h
MDA-MB-231 siRNA 19.2±4.8a 17.5±1.4a 16.6±3.7a   9.9±2.2a
si-NC   9.1±5.1   4.1±2.2   4.6±1.9   −1.5±3.7
SGC-7901 siRNA   9.0±0.8 15.5±5.6   5.3±1.8   6.8±4.8a
si-NC   5.2±3.5   8.3±5.0   1.1±4.1   1.1±3.7
HeLa siRNA   7.1±2.2 18.6±2.2 25.5±4.6a 46.3±1.8a
si-NC   8.6±3.6 18.3±3.4   5.8±4.2 33.2±4.3
A549 siRNA   4.0±1.0   1.4±2.2 25.4±2.5a 29.4±1.2a
si-NC   2.8±2.4   2.3±2.1   2.9±3.7   3.3±3.1
SK-OV-3 siRNA   1.2±2.1   2.8±4.0   −0.9±4.3   7.0±0.9a
si-NC   −1.7±3.3   3.0±3.2   −2.4±3.8   0.4±1.8
Raji siRNA   2.0±0.4   3.0±0.02   1.7±5.0 10.8±4.0a
si-NC   1.4±0.3   0.5±0.7   0.5±3.1   7.4±7.0
PC-3 siRNA   1.2±1.8   0.4±1.5   4.7±2.1   5.5±2.7a
si-NC   0.2±2.5   1.0±0.9   1.4±1.9   −0.5±4.1
a

P<0.05 vs. si-NC control group. siRNA, small interfering RNA; si-NC, scrambled negative control siRNA.